文献速递白血病

儿童复发B细胞前体急性淋巴细胞白血病中的非整倍体:检测复发低二倍体起源的临床重要性

Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
PubMed 文献 · Br J Haematol · 2019-02-03

该研究依据ALL-REZ BFM 2002方案治疗的413例首次复发B细胞前体急性淋巴细胞白血病患儿,采用DNA指数和多重连接依赖探针扩增着丝粒筛查检测非整倍体。高三倍体复发10年无事件生存率接近70%,低三倍体复发仅40%;明确或隐匿性低二倍体复发无事件生存率极低为9%。当前复发风险分层未将隐匿性低二倍体识别为高危,多因素分析显示低二倍体为独立预后因素。

要点

  • 高三倍体复发10年无事件生存率接近70%,低三倍体复发仅40%。
  • 明确或隐匿性低二倍体复发无事件生存率极低为9%。
  • 当前复发风险分层未将隐匿性低二倍体识别为高危。

核心结论

  • 低二倍体是儿童复发B细胞前体急性淋巴细胞白血病的独立预后因素,支持未来试验将低二倍体起源的复发分层至高危组或分配至替代治疗。

研究设计与样本

  • 研究纳入按ALL-REZ BFM 2002方案治疗的413例首次复发B细胞前体急性淋巴细胞白血病患儿,采用DNA指数和多重连接依赖探针扩增着丝粒筛查检测非整倍体。

主要发现

  • 高三倍体复发患者10年无事件生存率接近70%,低三倍体复发患者仅40%。
  • 3例表观高三倍体复发患者携带TP53突变,基于微阵列的等位基因分型显示低二倍体起源且低二倍体 founder 克隆缺失(隐匿性低二倍体)。
  • 明确或隐匿性低二倍体复发患者无事件生存率极低为9%。
  • 当前复发风险分层因临床表现良好未将隐匿性低二倍体病例识别为高危患者。
  • 多因素分析显示低二倍体为独立预后因素。

临床怎么用

  • 作者认为该发现支持未来试验将低二倍体起源的复发分层至高危组或分配患者至替代治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aneuploidy is common in paediatric B-cell precursor acute lymphoblastic leukaemia (ALL). Specific subgroups, such as high hyperdiploidy (>50 chromosomes or DNA Index ≥1·16) and hypodiploidy (<45 chromosomes), predict outcome of patients after primary treatment. Whether aneuploidy has a prognostic value for relapsed disease is yet to be determined. Using DNA index and centromere screening by multiplex ligation-dependent probe amplification, we investigated aneuploidy in 413 children treated for first relapse of B-cell precursor ALL according to the ALL-REZ BFM 2002 protocol. Ten-year event-free survival of patients with high hyperdiploid relapses approached 70%, whereas it was only 40% in low hyperdiploid relapses. Three patients with apparent hyperdiploid relapse had TP53 mutations. In these cases, array-based allelotyping revealed a hypodiploid origin with absence of the hypodiploid founder clone (masked hypodiploidy). Collectively, patients with evident or masked hypodiploid relapses showed an extremely low event-free survival rate of 9%. Importantly, the current relapse risk stratification did not identify cases with masked hypodiploidy as high-risk patients, due to their favourable clinical presentation. In multivariate analysis, hypodiploidy proved to be an independent prognostic factor. This finding supports stratification of relapses with hypodiploid origin into high-risk arms in future trials or allocation of patients to alternative treatment approaches.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Groeneveld-Krentz S, Schroeder MP, Reiter M, et al. Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse. Br J Haematol. 2019. PMID: 30714092. doi:10.1111/bjh.15770

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。